Betrixaban maleate is an oral anticoagulant that selectively inhibits Factor Xa, used to prevent venous thromboembolism (VTE) in acutely ill, hospitalized adults at risk of blood clots. It is the maleate salt form of betrixaban, marketed under the brand name Bevyxxa. It is grouped under the following drug class(es): Antithrombotic agents. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Bevyxxa, N-(5-chloropyridin-2-yl)-2-(4-(N and N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide maleate. Its PubChem CID is 16069304.
Betrixaban maleate
| CAS No | 936539-80-9 |
|---|---|
| Molecular Formula | C27H26ClN5O7 |
| Molecular Weight | 568.0 g/mol |
| Synonyms | (Z)-but-2-enedioic acid;N-(5-chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Betrixaban maleate is an oral anticoagulant that selectively inhibits Factor Xa, used to prevent venous thromboembolism (VTE) in acutely ill, hospitalized adults at risk of blood clots.
The listed CAS number is 936539-80-9.
The listed molecular formula is C27H26ClN5O7.
The listed molecular weight is 568.0 g/mol.
(Z)-but-2-enedioic acid;N-(5-chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide.
The source lists Bevyxxa, N-(5-chloropyridin-2-yl)-2-(4-(N and N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide maleate.